Cargando…

Combined Liver Stiffness and Α-fetoprotein Further beyond the Sustained Virologic Response Visit as Predictors of Long-Term Liver-Related Events in Patients with Chronic Hepatitis C

AIMS: Long-term risk stratification using combined liver stiffness (LS) and clinically relevant blood tests acquired at the baseline further beyond the sustained virologic response (SVR) visit for chronic hepatitis C (CHC) has not been thoroughly investigated. This study retrospectively investigated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Sheng-Hung, Lai, Hsueh-Chou, Su, Wen-Pang, Kao, Jung-Ta, Chuang, Po-Heng, Hsu, Wei-Fan, Wang, Hung-Wei, Hsieh, Tsung-Lin, Chen, Hung-Yao, Peng, Cheng-Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273470/ https://www.ncbi.nlm.nih.gov/pubmed/35837486 http://dx.doi.org/10.1155/2022/5201443

Ejemplares similares

Changes in liver stiffness measurement using acoustic radiation force impulse elastography after antiviral therapy in patients with chronic hepatitis C
por: Chen, Sheng-Hung, et al.
Publicado: (2018)

Effects of patient factors on noninvasive liver stiffness measurement using acoustic radiation force impulse elastography in patients with chronic hepatitis C
por: Chen, Sheng-Hung, et al.
Publicado: (2012)

Comparison of collagen proportionate areas in liver fibrosis quantification between chronic hepatitis B and C
por: Chen, Sheng-Hung, et al.
Publicado: (2016)

The Changes of Liver Stiffness and Its Associated Factors for Chronic Hepatitis B Patients with Entecavir Therapy
por: Kuo, Yuan-Hung, et al.
Publicado: (2014)

New noninvasive index for predicting liver fibrosis in Asian patients with chronic viral hepatitis
por: Wang, Hung-Wei, et al.
Publicado: (2017)

Association of sustained virologic response with reduced progression to liver cirrhosis in elderly patients with chronic hepatitis C
por: Tseng, Chih-Wei, et al.
Publicado: (2016)

Head-to-Head Comparison between Collagen Proportionate Area and Acoustic Radiation Force Impulse Elastography in Liver Fibrosis Quantification in Chronic Hepatitis C
por: Chen, Sheng-Hung, et al.
Publicado: (2015)

Publisher Correction: New noninvasive index for predicting liver fibrosis in Asian patients with chronic viral hepatitis
por: Wang, Hung-Wei, et al.
Publicado: (2018)

Association of α-fetoprotein levels with liver stiffness measurement in outpatients with chronic hepatitis B
por: Wang, Juan, et al.
Publicado: (2021)

Do peripartum and postmenopausal women with primary liver cancer have a worse prognosis? A nationwide cohort in Taiwan
por: Tseng, Guan-Woei, et al.
Publicado: (2021)

The change in liver stiffness, controlled attenuation parameter and fibrosis-4 index for chronic hepatitis C patients with direct-acting antivirals
por: Lee, Yu-Chi, et al.
Publicado: (2019)

Long-term surveillance of liver histological changes in chronic hepatitis C patients completing pegylated interferon-α plus ribavirin therapy: an observational cohort study
por: Hsieh, Ming-Han, et al.
Publicado: (2022)

Plasma interleukin-17 and alpha-fetoprotein combination effectively predicts imminent hepatocellular carcinoma occurrence in liver cirrhotic patients
por: Liang, Kung-Hao, et al.
Publicado: (2021)

Longitudinal assessment of liver stiffness by transient elastography for chronic hepatitis C patients
por: Mezina, Anya, et al.
Publicado: (2022)

Pyogenic Liver Abscess Risk in Patients With Newly Diagnosed Type 2 Diabetes Mellitus: A Nationwide, Population-Based Cohort Study
por: Wang, Tzu-Yuan, et al.
Publicado: (2021)

Risk Score Model for Microvascular Invasion in Hepatocellular Carcinoma: The Role of Tumor Burden and Alpha-Fetoprotein
por: Lee, Jin-Chiao, et al.
Publicado: (2021)

Beyond liver cancer, more application scenarios for alpha-fetoprotein in clinical practice
por: Ma, Chenyu, et al.
Publicado: (2023)

Aspartate aminotransferase to platelet ratio index and sustained virologic response are associated with progression from hepatitis C associated liver cirrhosis to hepatocellular carcinoma after treatment with pegylated interferon plus ribavirin
por: Ng, Khai-Jing, et al.
Publicado: (2016)

Infantile mesenchymal hamartoma of the liver with elevated alpha fetoprotein
por: Le, Liem Thanh, et al.
Publicado: (2021)

Does pyogenic liver abscess increase the risk of delayed-onset primary liver cancer?: Evidence from a nationwide cohort study
por: Chu, Chia-Sheng, et al.
Publicado: (2017)

Kinetics in HBsAg after Stopping Entecavir or Tenofovir in Patients with Virological Relapse but Not Clinical Relapse
por: Tseng, Tzu-Ning, et al.
Publicado: (2022)

Evaluation of high-risk factors and the diagnostic value of alpha-fetoprotein in the stratification of primary liver cancer
por: Jiao, Hong-Bin, et al.
Publicado: (2022)

On-Treatment Changes in FIB-4 and 1-Year FIB-4 Values Help Identify Patients with Chronic Hepatitis B Receiving Entecavir Therapy Who Have the Lowest Risk of Hepatocellular Carcinoma
por: Wang, Hung-Wei, et al.
Publicado: (2020)

Well-differentiated gall bladder hepatoid carcinoma producing alpha-fetoprotein: a case report
por: Kao, Ching-Yun, et al.
Publicado: (2009)

Rapid decline of noninvasive fibrosis index values in patients with hepatitis C receiving treatment with direct-acting antiviral agents
por: Hsu, Wei-Fan, et al.
Publicado: (2019)

The Application of Liver Stiffness Measurement in Residents Without Overt Liver Diseases Through a Community-Based Screening Program
por: Cheng, Pin-Nan, et al.
Publicado: (2016)

Liver stiffness regression after sustained virological response by direct-acting antivirals reduces the risk of outcomes
por: Piedade, Juliana, et al.
Publicado: (2021)

Association between systemic sclerosis and peripheral arterial disease: a nationwide observation retrospective claim records cohort study in Taiwan
por: Hsieh, Ming-Chia, et al.
Publicado: (2021)

On-Treatment Albumin-Bilirubin Grade: Predictor of Response and Outcome of Sorafenib-Regorafenib Sequential Therapy in Patients with Unresectable Hepatocellular Carcinoma
por: Wang, Hung-Wei, et al.
Publicado: (2021)

Effect of delta α-fetoprotein on the detection of liver cancer recurrence
por: Sun, Li-Yue, et al.
Publicado: (2020)

Sustained virological response and metabolic risk factors are associated with mortality in patients with chronic hepatitis C
por: Yen, Yi-Hao, et al.
Publicado: (2019)

Antiarrhythmic Agents and the Risk of Malignant Neoplasm of Liver and Intrahepatic Bile Ducts
por: Lim, Yun-Ping, et al.
Publicado: (2015)

Regorafenib for Taiwanese patients with unresectable hepatocellular carcinoma after sorafenib failure: Impact of alpha‐fetoprotein levels
por: Hsu, Po‐Yao, et al.
Publicado: (2021)

Evaluation of dose-efficacy of sorafenib and effect of transarterial chemoembolization in hepatocellular carcinoma patients: a retrospective study
por: Hsiao, Wang-De, et al.
Publicado: (2016)

Diabetes influences liver stiffness in chronic hepatitis C patients with and without virological cure: A longitudinal study
por: Pontual, Daniela Malta, et al.
Publicado: (2021)

Spontaneous rupture of metastatic α-fetoprotein-producing gastric cancer of the liver
por: Sohda, Tetsuro, et al.
Publicado: (2008)

Normal Alpha-Fetoprotein Hepatocellular Carcinoma: Are They Really Normal?
por: Lee, Chao-Wei, et al.
Publicado: (2019)

Living donor liver transplantation for Barcelona clinic liver cancer (BCLC) intermediate-stage hepatocellular carcinoma
por: Tsai, Ming Chao, et al.
Publicado: (2022)

Clinical Considerations of Coagulopathy in Acute Liver Failure
por: Kim, Ahyoung, et al.
Publicado: (2020)

Clinical relevance of alpha-fetoprotein in determining resection margin for hepatocellular carcinoma
por: Lee, Jin-Chiao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4von4aa10va3v952dr6ufk2qq3